OliverBraubach United States

OliverBraubach
Oliver Braubach joined Bruker as the Director of Research and Development in 2023. He is responsible for the ongoing development of the CellScape™ Precise Spatial Proteomics platform. The CellScape enables precise spatial multiplexing of proteins at any plex-level with cellular and subcellular resolution. Oliver’s R&D team is based in St. Louis, MO and Hannover, Germany. The team is committed to developing turnkey solutions for spatial multiplexing in discovery, translational and clinical research. Oliver has more than 15 years of experience in imaging and spatial biology, and he actively publishes research related to cancer immunology, neuroscience and infectious disease. Oliver received his PhD from Dalhousie University, Canada, and has developed multiple techniques aimed at democratizing and maximizing biomarker detection with optical microscopy.

Monday 08 June 2026

Time Session
12:15
13:00
Bruker Industry Symposium: Expanding the Frontiers of Spatial Biology: Best-in-Class Solutions for Every Layer of Biology
Biology is complex, and the mechanisms that drive biological systems are challenging to decipher. Examining any single layer of biology can provide a valuable perspective, but it reveals only part of the picture. Bruker Spatial Biology delivers best-in-class solutions designed to work together as a cohesive ecosystem. By providing high fidelity resolution and information depth across layers of biological complexity, Bruker Spatial Biology enables insights that cannot be achieved by single layer approaches, accelerating discovery through translational cancer research. Prof. Pagani will exemplify how his laboratory is using CosMx Same-Cell Multiomics to determine metastatic cell states in colorectal cancer.
Room F9+10